Why Competitive Intelligence Has Become Central to Pharmaceutical and Biotech Strategy
Pharmaceutical competition rarely changes through a single event. A company's strategic position can shift following a clinical milestone, licensing agreement, patent development, regulatory decision, manufacturing expansion, acquisition or investment. Each event may appear isolated, but together these signals can reveal changes in pipeline strength, market positioning or commercial intent.
BioSignalIQ (https://www.rootsanalysis.com/biosignaliq )